Flagship Harbor Advisors LLC Grows Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Flagship Harbor Advisors LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.2% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 3,165 shares of the medical equipment provider’s stock after purchasing an additional 97 shares during the period. Flagship Harbor Advisors LLC’s holdings in Intuitive Surgical were worth $1,652,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Linden Thomas Advisory Services LLC grew its stake in Intuitive Surgical by 5.8% during the 4th quarter. Linden Thomas Advisory Services LLC now owns 10,217 shares of the medical equipment provider’s stock valued at $5,333,000 after purchasing an additional 562 shares in the last quarter. Cyndeo Wealth Partners LLC grew its position in shares of Intuitive Surgical by 4.9% during the fourth quarter. Cyndeo Wealth Partners LLC now owns 8,786 shares of the medical equipment provider’s stock worth $4,586,000 after buying an additional 407 shares in the last quarter. Fifth Third Bancorp increased its stake in shares of Intuitive Surgical by 7.0% in the fourth quarter. Fifth Third Bancorp now owns 199,932 shares of the medical equipment provider’s stock worth $104,357,000 after buying an additional 12,998 shares during the last quarter. DGS Capital Management LLC raised its holdings in Intuitive Surgical by 9.3% in the fourth quarter. DGS Capital Management LLC now owns 1,813 shares of the medical equipment provider’s stock valued at $946,000 after acquiring an additional 154 shares in the last quarter. Finally, Bennett Selby Investments LP boosted its stake in Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after acquiring an additional 17 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the transaction, the insider now directly owns 8,757 shares in the company, valued at approximately $4,597,425. This trade represents a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 42,453 shares of company stock valued at $22,059,506. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Down 4.0 %

Shares of ISRG opened at $584.05 on Monday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm has a market capitalization of $208.03 billion, a PE ratio of 93.90, a P/E/G ratio of 5.19 and a beta of 1.39. The firm has a 50-day moving average price of $547.16 and a 200 day moving average price of $504.78.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on ISRG shares. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Stifel Nicolaus upped their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Finally, Raymond James lifted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $583.83.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.